S
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
HKEX:6990
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
HKEX:6990
Price:
432.2
HKD
0.19%
Market Cap:
HK$100.8B
Relative Value
The Relative Value of one Sichuan Kelun-Biotech Biopharmaceutical Co Ltd stock under the Base Case scenario is hidden HKD. Compared to the current market price of 432.2 HKD, Sichuan Kelun-Biotech Biopharmaceutical Co Ltd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd Relative Value
HIDDEN
Multiples Across Competitors
Competitors Multiples
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd Competitors
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
S
|
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
HKEX:6990
|
100.8B HKD | 59.1 | -122.8 | -108.5 | -108.5 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
364.6B USD | 6 | 87.1 | 14.5 | 20.1 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
188.6B USD | 5.1 | 24.4 | 14.2 | 14.2 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
175.1B USD | 6 | 20.6 | 12.9 | 15.9 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
116.3B USD | 9.7 | 29.4 | 22.2 | 23.1 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
77.9B USD | 5.4 | 17.3 | 12.7 | 14.5 | |
| AU |
|
CSL Ltd
ASX:CSL
|
66.7B AUD | 3.1 | 33.9 | 11.2 | 14.1 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 | |
| NL |
|
argenx SE
XBRU:ARGX
|
36.4B EUR | 10.3 | 33.1 | 35.8 | 36.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
